| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |